It's beginning to look a lot like Christmas! Grab a cup of hot cocoa and enjoy this week's Roundup.
- It’s the most forecasty time of the year (Barry Ritholtz, The Big Picture). Beware: Making investment moves based on predictions is "a terrible way to manage a portfolio."
- Is the correction over? (Michael Batnick, The Irrelevant Investor). Technically, it wasn't a "correction" — defined as a market decline of 10%. But the post-Thanksgiving plummet and rapid bounceback made heads spin.
- What retirees could expect in 2022 (Mark Miller, Morningstar). "The unique challenges posed by inflation will be the top story in the year ahead."
- Series I savings bonds: End-of-year strategies to take advantage of the current high interest rate (Jeffrey Levine, Kitces.com). Get 'em while they're hot.
- Key considerations if you're eyeing a Medigap policy to help cover Medicare costs (CNBC). Medigap is optional, but it may be a wise choice for those who opt for traditional Medicare rather than the more market-oriented Medicare Advantage.
- 'Effectively overcharges seniors': AARP rakes in record profits selling brand royalties while overcharging members (Daily Caller). Medigap policies bring in the most revenue for AARP, according to the author of an investigative report.
- Starting early (John Yeigh, Humble Dollar). Thoughts on setting up a Roth IRA for a teenager.
- The mutual fund that ate Wall Street (The Wall Street Journal). The Vanguard Total Stock Market Index Fund now accounts for 10% of all assets invested in U.S. stock funds and ETFs.
- Fit to retire (James Kerr, Humble Dollar). Are you a disciplined investor? Great! Are you equally disciplined about your health and fitness?
- The 12 Days of Christmas are more expensive this year (CNBC). The price increase "parallels inflationary growth in the broad U.S. economy." (In case you're wondering, the 12 days run from December 25–January 5.)
Have a comment? "Join the Discussion" below!